Long Noncoding RNAs CAT2064 and CAT2042 may Function as Diagnostic Biomarkers for Prostate Cancer by Affecting Target MicrorRNAs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long Noncoding RNAs CAT2064 and CAT2042 may Function as Diagnostic Biomarkers for Prostate Cancer by Affecting Target MicrorRNAs

Published:2021-08-24 Issue: Volume: Page:
ISSN:0970-1915
Container-title:Indian Journal of Clinical Biochemistry
language:en
Short-container-title:Ind J Clin Biochem

Author:

Amirmahani Farzane,Ebrahimi Nasim,Askandar Rafee Habib,Rasouli Eshkaftaki Marzieh,Fazeli Katayoun,Hamblin Michael R.

Funder

national institutes of health

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s12291-021-00999-6.pdf

Reference30 articles.

1. Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63.

2. Wang G, Zhao D, Spring DJ, et al. Genetics and biology of prostate cancer. Genes Dev. 2018;32(17–18):1105–40.

3. Pannek J, Partin A. Prostate-specific Antigen: What's new in Oncology (Williston Park). 1997.

4. Magi-Galluzzi C, Tsusuki T, Elson P, et al. TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients. Prostate. 2011;71(5):489–97.

5. Ren S, Liu Y, Xu W, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190(6):2278–87.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs;European Journal of Medical Research;2024-08-08

2. Genome-wide investigation of lncRNAs revealed their tight association with gastric cancer;Journal of Cancer Research and Clinical Oncology;2024-05-18

3. Prostate cancer: Novel genetic and immunologic biomarkers;Clinica Chimica Acta;2024-03

4. Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer;Cellular and Molecular Life Sciences;2022-10-29

5. Crosstalk between non-coding RNAs expression profile, drug resistance and immune response in breast cancer;Pharmacological Research;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3